Publications by authors named "Moeber Mohammed Mahzari"
Corrigendum to "Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes" [J. Clin. Translat. Endoc. 36C (2024) 100343].
J Clin Transl Endocrinol
December 2024
[This corrects the article DOI: 10.1016/j.jcte.
View Article and Find Full Text PDFArticle Synopsis
- - Graves' disease is an autoimmune disorder causing hyperthyroidism, often treated with anti-thyroid drugs (ATD), radioactive iodine, or surgery, but data on long-term remission with ATD in Saudi Arabia is limited.
- - A study of 189 patients treated with ATD showed that 54.5% achieved remission, with those in remission having lower free T4 levels and TRAb titers compared to non-remitters.
- - Out of the patients who achieved remission, 34% relapsed after stopping ATD, with relapsing patients showing higher thyroid uptake on scans and longer duration of ATD treatment compared to non-relapsers.
Objective: Type 2 diabetes mellitus (T2DM) and post-transplant diabetes mellitus (PTDM) are common in renal transplant recipients. Semaglutide has demonstrated efficacy and safety in patients with T2DM. To date, only a limited number of studies have investigated its use in renal transplant patients.
View Article and Find Full Text PDFBackground: Self-explanation while individually diagnosing clinical cases has proved to be an effective instructional approach for teaching clinical reasoning. The present study compared the effects on diagnostic performance of self-explanation in small groups with the more commonly used hypothetico-deductive approach.
Methods: Second-year students from a six-year medical school in Saudi Arabia (39 males; 49 females) worked in small groups on seven clinical vignettes (four criterion cases representing cardiovascular diseases and three 'fillers', i.